Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ranson

Showing results (61-70 of 158) with videos related to

Pageof 16
Sort By:
British Journal of Cancer|March 20, 2003
Preclinical studies of targeted alpha therapy for breast cancer using 213Bi-labelled-plasminogen activator inhibitor type 2B J Allen, Z Tian, S M A Rizvi, et al.
American Journal of Preventive Medicine|April 21, 2023
Socioeconomic Deprivation, Genetic Risk, and Incident DementiaMatthias Klee, Anja K Leist, Michele Veldsman, et al.
The Journal of Investigative Dermatology|June 1, 1988
Human melanoma cells: functional modulation by calciotropic hormonesR S Mason, A M Pryke, M Ranson, et al.
British Journal of Cancer|December 1, 1995
Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: a randomised phase II studyD C Betticher, H Anderson, M Ranson, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1997
Phase II trial of rhIL-6 (interleukin-6) prior to and concurrently with VAD (vincristine, doxorubicin and dexamethasone) chemotherapy for patients with multiple myelomaR I Young, M Ranson, J Chang, et al.
Dalton Transactions (Cambridge, England : 2003)|April 13, 2010
Tailoring the photoluminescence properties of transition metal phosphonatesRichard Singleton, James Bye, James Dyson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapyJ Prendiville, J Radford, N Thatcher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Randomised phase II study of cisplatin-etoposide versus infusional carboplatin in advanced non-small-cell lung cancer and mesotheliomaS C White, H Anderson, G C Jayson, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Review of recent trials of chemotherapy for advanced breast cancer: studies excluding taxanesM Clemons, M Leahy, J Valle, et al.
Journal of Affective Disorders|December 5, 2024
Association of aging acceleration with serum neurofilament light chain levels: Implications for the roles of modifiable aging factorsLiwei Tang, Min Liu, Yifan Tao, et al.
Pageof 16

Showing results (61-70 of 158) with videos related to

Sort By:
Pageof 16
British Journal of Cancer|March 20, 2003
Preclinical studies of targeted alpha therapy for breast cancer using 213Bi-labelled-plasminogen activator inhibitor type 2B J Allen, Z Tian, S M A Rizvi, et al.
American Journal of Preventive Medicine|April 21, 2023
Socioeconomic Deprivation, Genetic Risk, and Incident DementiaMatthias Klee, Anja K Leist, Michele Veldsman, et al.
The Journal of Investigative Dermatology|June 1, 1988
Human melanoma cells: functional modulation by calciotropic hormonesR S Mason, A M Pryke, M Ranson, et al.
British Journal of Cancer|December 1, 1995
Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: a randomised phase II studyD C Betticher, H Anderson, M Ranson, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1997
Phase II trial of rhIL-6 (interleukin-6) prior to and concurrently with VAD (vincristine, doxorubicin and dexamethasone) chemotherapy for patients with multiple myelomaR I Young, M Ranson, J Chang, et al.
Dalton Transactions (Cambridge, England : 2003)|April 13, 2010
Tailoring the photoluminescence properties of transition metal phosphonatesRichard Singleton, James Bye, James Dyson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapyJ Prendiville, J Radford, N Thatcher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Randomised phase II study of cisplatin-etoposide versus infusional carboplatin in advanced non-small-cell lung cancer and mesotheliomaS C White, H Anderson, G C Jayson, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Review of recent trials of chemotherapy for advanced breast cancer: studies excluding taxanesM Clemons, M Leahy, J Valle, et al.
Journal of Affective Disorders|December 5, 2024
Association of aging acceleration with serum neurofilament light chain levels: Implications for the roles of modifiable aging factorsLiwei Tang, Min Liu, Yifan Tao, et al.
Pageof 16